These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
118 related items for PubMed ID: 15739624
1. Differential diagnosis of cholestasis following allogeneic hematopoietic stem cell transplantation in children: the contribution of serum bile acid levels in relation to other liver function tests. Zakrzewski JL, Ballauff A, Wieland R, Basu O, Kremens B. Pediatr Hematol Oncol; 2004 Dec; 21(8):697-705. PubMed ID: 15739624 [Abstract] [Full Text] [Related]
3. Hepatitic graft-versus-host disease after hematopoietic stem cell transplantation: clinicopathologic features and prognostic implication. Ma SY, Au WY, Ng IO, Lie AK, Leung AY, Liang R, Lau GK, Kwong YL. Transplantation; 2004 Apr 27; 77(8):1252-9. PubMed ID: 15114094 [Abstract] [Full Text] [Related]
4. Enlargement of the common bile duct in patients with acute graft-versus-host disease: what does it mean? Ketelsen D, Vogel W, Bethge W, Werner M, Dietz K, Claussen CD, Horger M. AJR Am J Roentgenol; 2009 Sep 27; 193(3):W181-5. PubMed ID: 19696256 [Abstract] [Full Text] [Related]
5. Serum bile acids and esterified bilirubin in early detection and differential diagnosis of hepatic dysfunction following orthotopic liver transplantation. Muraca M, Kohlhaw K, Vilei MT, Ringe B, Bunzendahl H, Gubernatis G, Wonigeit K, Brunner G, Pichlmayr R. J Hepatol; 1993 Feb 27; 17(2):141-5. PubMed ID: 8445227 [Abstract] [Full Text] [Related]
6. [Analysis of acute liver "graft-versus-host disease" following allogeneic myeloablative stem cell transplant]. Doki N, Saito Y, Hatsumi N, Irisawa H, Sakura T, Miyawaki S. Rinsho Ketsueki; 2004 Jan 27; 45(1):57-60. PubMed ID: 14999935 [Abstract] [Full Text] [Related]
7. [Liver biopsy in the management of liver dysfunction after allogeneic hematopoietic stem-cell transplantation]. Chen H, Huang XJ, Liu KY, Xu LP, Wang H, Liu DH, Lu J, Lu DP. Zhonghua Yi Xue Za Zhi; 2005 Nov 16; 85(43):3062-6. PubMed ID: 16324408 [Abstract] [Full Text] [Related]
8. Hepatic graft-versus-host disease presenting as an acute hepatitis after allogeneic peripheral blood stem cell transplantation. Fujii N, Takenaka K, Shinagawa K, Ikeda K, Maeda Y, Sunami K, Hiramatsu Y, Matsuo K, Ishimaru F, Niiya K, Yoshino T, Hirabayashi N, Harada M. Bone Marrow Transplant; 2001 May 16; 27(9):1007-10. PubMed ID: 11436113 [Abstract] [Full Text] [Related]
9. Serum bile acids and rountine liver function tests in patients with chronic liver disease and cholestasis. Collins DM, Tongeren AV, Cook HB, Campbell CB. N Z Med J; 1979 Jun 13; 89(637):432-4. PubMed ID: 289016 [Abstract] [Full Text] [Related]
15. Risk factors associated with liver injury and impact of liver injury on transplantation-related mortality in pediatric recipients of allogeneic hematopoietic stem cell transplantation. Radhakrishnan K, Bishop J, Jin Z, Kothari K, Bhatia M, George D, Garvin JH, Martinez M, Ovchinsky N, Lobritto S, Elsayed Y, Satwani P. Biol Blood Marrow Transplant; 2013 Jun 13; 19(6):912-7. PubMed ID: 23467127 [Abstract] [Full Text] [Related]
16. Iron overload manifesting as apparent exacerbation of hepatic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Kamble RT, Selby GB, Mims M, Kharfan-Dabaja MA, Ozer H, George JN. Biol Blood Marrow Transplant; 2006 May 13; 12(5):506-10. PubMed ID: 16635785 [Abstract] [Full Text] [Related]
17. Oxidative stress markers, secondary bile acids and sulfated bile acids classify the clinical liver injury type: Promising diagnostic biomarkers for cholestasis. Masubuchi N, Sugihara M, Sugita T, Amano K, Nakano M, Matsuura T. Chem Biol Interact; 2016 Aug 05; 255():83-91. PubMed ID: 26325587 [Abstract] [Full Text] [Related]